RACHEL WEAVER: Open Payments
NPI 1952745374 · GAINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$610 in 34 payments from 10 companies in 2025. Trend: 2023 $493 · 2024 $777 · 2025 $610
Food & beverage: $610
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 15 | $152 |
| Abbott Laboratories | 1 | $146 |
| Lilly USA, LLC | 6 | $102 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $81 |
| Inspire Medical Systems, Inc. | 1 | $31 |
| Eisai Inc. | 1 | $28 |
| Phathom Pharmaceuticals, Inc. | 2 | $23 |
| PFIZER INC. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Axsome Therapeutics, Inc. | 1 | $14 |
Products named: PROCLAIM, OTEZLA, MOUNJARO, TRINTELLIX, INSPIRE, EVENITY, Leqembi, VOQUEZNA.
Industry payments across GA — which companies pay providers there.
